Skip to main content
. 2001 Dec 21;8(4):276–283. doi: 10.1046/j.1365-2893.2001.00297.x

Table 3.

 Adverse events during treatment with IFN‐α2a with and without amantadine sulphate

graphic file with name JVH-8-276-g005.jpg